Compugen Ltd

-0.15 (-3.94%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)295.14M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1 Million
Adjusted EPS-$0.13
See more estimates
10-Day MA$3.87
50-Day MA$4.42
200-Day MA$6.48
See more pivots

Compugen Ltd Stock, NASDAQ:CGEN

Azrieli Center, 26 Harokmim Street, Holon, Tel Aviv 58858
Phone: +972.3.765.8585
Number of Employees: 68


Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.